Xiangyu Medical Co. Ltd. A (688626) — Cash Flow Reinvestment Rate
Xiangyu Medical Co. Ltd. A (688626) has a Cash Flow Reinvestment Rate of 3.23x as of September 2025, reinvesting CN¥58.35 Million (capex CN¥58.35 Million ) from operating cash flow of CN¥18.05 Million. Check 688626 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xiangyu Medical Co. Ltd. A Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for Xiangyu Medical Co. Ltd. A across 8 annual periods. Explore debt repayment capacity of Xiangyu Medical Co. Ltd. A to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Xiangyu Medical Co. Ltd. A (2017–2024)
Year-by-year capital reinvestment analysis for Xiangyu Medical Co. Ltd. A. For live market cap and broader valuation context, see Xiangyu Medical Co. Ltd. A (688626) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.46x | CN¥439.95 Million | CN¥178.59 Million | CN¥438.89 Million | ▼ -21.3% |
| 2023 | 3.13x | CN¥713.80 Million | CN¥227.91 Million | CN¥479.26 Million | ▲ +53.1% |
| 2022 | 2.05x | CN¥381.98 Million | CN¥186.70 Million | CN¥203.07 Million | ▼ -62.9% |
| 2021 | 5.52x | CN¥915.95 Million | CN¥165.88 Million | CN¥133.91 Million | ▲ +328.1% |
| 2020 | 1.29x | CN¥279.12 Million | CN¥216.40 Million | CN¥139.71 Million | ▼ -4.3% |
| 2019 | 1.35x | CN¥210.20 Million | CN¥155.94 Million | CN¥21.07 Million | ▲ +1325.5% |
| 2018 | 0.09x | CN¥7.02 Million | CN¥74.20 Million | CN¥7.02 Million | ▼ -62.2% |
| 2017 | 0.25x | CN¥14.84 Million | CN¥59.31 Million | CN¥14.84 Million | — |